FRANK MORGAN C. 4
4 · SANUWAVE Health, Inc. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
SANUWAVE (SNVW) CEO Frank Morgan Receives 3,208-Unit Award
What Happened Frank Morgan, CEO of SANUWAVE Health, was granted an award of 3,208 derivative securities on March 31, 2026. The Form 4 reports the acquisition at $0.00 per unit (total reported cash outlay $0). The filing classifies the transaction as an award/grant rather than a purchase or sale.
Key Details
- Transaction date: 2026-03-31; Form 4 filed 2026-04-02 (appears to be timely filed).
- Security: 3,208 derivative shares/options awarded at $0.00 per unit.
- Shares owned after transaction: not specified in the details provided.
- Footnote: the options were fully vested at the grant date (immediate vesting).
- Transaction type code: A = Award/Grant (derivative).
Context This was an equity award to an executive, not an open-market purchase or sale. For derivative awards, the footnote indicates the options were fully vested on grant—meaning the award was immediately vested per the filing. Such grants are common as compensation and do not, by themselves, indicate a purchase or sale intent.
Insider Transaction Report
Form 4
FRANK MORGAN C.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
[F1]2026-03-31+3,208→ 3,208 totalExercise: $17.29Exp: 2031-03-31→ Common Stock (3,208 underlying)
Footnotes (1)
- [F1]Options were fully vested at the grant date.
Signature
/s/ Griffin D. Foster, Attorney-in-Fact for Morgan C. Frank|2026-04-02